E-drug: Illegal promotion of Letrozole in India (cont'd)
---------------------------------------------------------------------
It is good to read the informative e-mail on illegal promotion of
Letrozole in India. I already read about this in the Hindustan Times
(HT) and the counteract suit filed by Sun Pharmaceuticals against the
HT, but now I understand it better. Patients should be informed about
this adverse drug reaction to prevent serious harm and to improve
public health. Adverse drug reaction monitoring should be stressed.
Regards,
S. Ziaur Rahman
Lecturer
Department of Pharmacology
J. N. Medical College
Aligarh Muslim University
Aligarh-202002 INDIA
Tel.+91-571-2400452 (R); 2720358 (W)
e-mail: rahmansz@sancharnet.in
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug